Skip to content

Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients

Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients With Headache and Dizziness or Epilepsy and Clinical Indication for an Angiography by Magnetic Imaging

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00132223
Enrollment
10
Registered
2005-08-19
Start date
2005-04-30
Completion date
2005-12-31
Last updated
2006-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache, Epilepsy, Dizziness

Keywords

magnetic imaging, angiography, contrast agent, signal/noise ratio, contrast/noise ratio, vessel

Brief summary

Angiographies of the supra-aortic vessels by magnetic imaging have become common recently. So it was the purpose of this study to evaluate the imaging potential of different contrast agents. Three contrast agents for magnetic resonance imaging are compared in angiographies of the supra-aortic arteries in a intraindividual study of 10 patients. All applications of these contrast agents are performed with a flow of 2 ml/s. One contrast medium is applicated a second time with a reduced flow of 1 ml/s. The angiographies of the supra-aortic vessels are evaluated by two experienced readers in a consensus reading. The signal/noise- and contrast/noise-ratio of anatomic vessel segments of the carotic and vertebral arteries are measured and compared to each other.

Interventions

Sponsors

University Hospital Muenster
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Headache * Epilepsia * Dizziness

Exclusion criteria

* Pregnancy * Metal implants (e.g. pacemaker) * Contraindication for contrast agent * Multiple allergies

Design outcomes

Primary

MeasureTime frame
intensity of vessels, muscle, air

Secondary

MeasureTime frame
signal/noise ratio
contrast/nose ratio

Countries

Germany

Contacts

Primary ContactBoris Buerke, MD
buerkeb@uni-muenster.de00492518345123
Backup ContactBernd Tombach, MD
tombach@uni-muenster.de00492518345123

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026